You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API infliximab

✉ Email this page to a colleague

« Back to Dashboard

Detailed excipient profiles for infliximab

Excipient focus: ACETIC ACID

infliximab drug variants containing ACETIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
CELLTRION USA Inc	infliximab-dyyb	72606-025
>Company	>Ingredient	>NDC

infliximab drug variants not containing ACETIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merck Sharp & Dohme LLC	infliximab	0006-4305
Janssen Biotech Inc	infliximab	57894-030
Janssen Biotech Inc	infliximab	57894-160
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 80

infliximab drug variants containing POLYSORBATE 80

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merck Sharp & Dohme LLC	infliximab	0006-4305
Janssen Biotech Inc	infliximab	57894-030
Janssen Biotech Inc	infliximab	57894-160
>Company	>Ingredient	>NDC

infliximab drug variants not containing POLYSORBATE 80

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM ACETATE

infliximab drug variants containing SODIUM ACETATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
CELLTRION USA Inc	infliximab-dyyb	72606-025
>Company	>Ingredient	>NDC

infliximab drug variants not containing SODIUM ACETATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merck Sharp & Dohme LLC	infliximab	0006-4305
Janssen Biotech Inc	infliximab	57894-030
Janssen Biotech Inc	infliximab	57894-160
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

infliximab drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Amgen Inc	infliximab-axxq	55513-670
>Company	>Ingredient	>NDC

infliximab drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merck Sharp & Dohme LLC	infliximab	0006-4305
Janssen Biotech Inc	infliximab	57894-030
Janssen Biotech Inc	infliximab	57894-160
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, DIHYDRATE

infliximab drug variants containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Janssen Biotech Inc	infliximab	57894-030
Janssen Biotech Inc	infliximab	57894-160
Pfizer Laboratories Div Pfizer Inc	infliximab-dyyb	0069-0809
>Company	>Ingredient	>NDC

infliximab drug variants not containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merck Sharp & Dohme LLC	infliximab	0006-4305
Organon LLC	infliximab	78206-162
Amgen Inc	infliximab-axxq	55513-670
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

infliximab drug variants containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merck Sharp & Dohme LLC	infliximab	0006-4305
Organon LLC	infliximab	78206-162
>Company	>Ingredient	>NDC

infliximab drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Janssen Biotech Inc	infliximab	57894-030
Janssen Biotech Inc	infliximab	57894-160
Amgen Inc	infliximab-axxq	55513-670
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

infliximab drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merck Sharp & Dohme LLC	infliximab	0006-4305
Janssen Biotech Inc	infliximab	57894-030
Janssen Biotech Inc	infliximab	57894-160
>Company	>Ingredient	>NDC

infliximab drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
CELLTRION USA Inc	infliximab-dyyb	72606-025
>Company	>Ingredient	>NDC

Excipient focus: SORBITOL

infliximab drug variants containing SORBITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
CELLTRION USA Inc	infliximab-dyyb	72606-025
>Company	>Ingredient	>NDC

infliximab drug variants not containing SORBITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merck Sharp & Dohme LLC	infliximab	0006-4305
Janssen Biotech Inc	infliximab	57894-030
Janssen Biotech Inc	infliximab	57894-160
>Company	>Ingredient	>NDC

Excipient focus: SUCROSE

infliximab drug variants containing SUCROSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merck Sharp & Dohme LLC	infliximab	0006-4305
Janssen Biotech Inc	infliximab	57894-030
Janssen Biotech Inc	infliximab	57894-160
>Company	>Ingredient	>NDC

infliximab drug variants not containing SUCROSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
CELLTRION USA Inc	infliximab-dyyb	72606-025
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.